Loading clinical trials...
Loading clinical trials...
Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules and EFEXOR® XR Under Fed Conditions in Chinese Healthy Volunteers
Conditions
Interventions
Venlafaxine Hydrochloride Sustained-Release Capsules 75 mg
EFEXOR® XR
Locations
1
China
Institution of Drug Clinical Trials
Beijing, Beijing Municipality, China
Start Date
January 2, 2020
Primary Completion Date
April 2, 2020
Completion Date
July 2, 2020
Last Updated
January 18, 2020
NCT06969963
NCT06924190
NCT06600282
NCT06579053
NCT06549504
NCT05436769
Lead Sponsor
Beijing Tongren Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions